Pediatric Asthma Work-Up
Initial Evaluation for Children Aged 5-16 Years
The European Respiratory Society strongly recommends performing spirometry, bronchodilator reversibility (BDR) testing, and fractional exhaled nitric oxide (FeNO) measurement as first-line diagnostic tests, with at least two abnormal objective test results required to confirm asthma diagnosis. 1
Clinical History Assessment
Focus your history on these specific high-yield elements:
- Wheeze characteristics: Document frequency (>3 attacks per year has 44% sensitivity and 90% specificity), timing, and whether the child awakens due to wheeze 2
- Specific triggers: Ask specifically about pollen exposure (46% sensitivity, 83% specificity) and pet exposure (29% sensitivity, 99% specificity) 2
- Avoid relying on nonspecific symptoms: Cough alone or breathing difficulty without wheeze are poor predictors and should prompt investigation for alternative diagnoses 3, 4
First-Line Objective Testing (Ages 5-16)
Perform these tests in sequence:
FeNO measurement (perform before spirometry): Use cut-off ≥25 ppb; elevated levels suggest eosinophilic airway inflammation (AUC 0.80) 1, 2
Spirometry: Measure FEV₁ and FEV₁/FVC ratio; abnormal is defined as <lower limit of normal (LLN) or <80% predicted 1
Bronchodilator reversibility testing: Perform even if spirometry is normal when clinical suspicion is high (AUC 0.81 for methacholine challenge) 1, 2
Diagnostic Decision Algorithm
- Confirm asthma: When ≥2 objective tests are abnormal (e.g., abnormal spirometry + positive BDR, or elevated FeNO + positive BDR) 1, 4
- If initial tests normal but symptomatic: Repeat testing when the child presents with active symptoms, particularly when wheezing is present 3, 4
- If tests normal and relatively asymptomatic: Consider "watchful waiting" with scheduled follow-up 3, 4
Additional Testing When Diagnosis Remains Unclear
- Peak flow variability: Only consider in settings lacking other objective tests; requires 2 weeks of twice-daily measurements with ≥12% variability as positive cut-off 4, 5
- Exercise or methacholine challenge: These have higher diagnostic accuracy (AUC 0.74-0.81) than baseline spirometry 2
Evaluation for Children Under 5 Years
In children aged 2-4 years who cannot reliably perform spirometry or peak flow measurements, use a therapeutic trial approach rather than attempting objective testing. 3, 5
Clinical Assessment for Young Children
- Document recurrent wheeze: This is the most important symptom suggesting asthma in this age group 3
- Assess symptom patterns: Note triggers (viral infections, exercise, allergens) and response to any previous treatments 3
- Avoid vague labels: Do not use terms like "bronchitis" or "reactive airway disease" as these delay proper diagnosis 3
Therapeutic Trial Protocol
When objective testing is not feasible:
- Initiate inhaled corticosteroid (ICS) trial in symptomatic children 1
- Do NOT diagnose based on symptom improvement alone 1, 3
- Reassess after 4-8 weeks with repeat attempt at objective testing if age-appropriate 1
- Consider supervised stepping down of preventer medication to confirm or refute active asthma 1
Critical Pitfalls to Avoid
- Never diagnose asthma on symptoms alone in children ≥5 years without objective testing 1, 4
- Do not use allergy testing (skin prick or IgE) to diagnose asthma: These have low specificity and should only identify triggers after diagnosis is established 3, 4
- Do not rely on single abnormal test: At least two objective abnormalities are required 1, 4
- Do not assume normal spirometry excludes asthma: Repeat when symptomatic 1, 3
- Avoid diagnosing based solely on treatment response: Symptom improvement after ICS trial must be accompanied by objective improvement in lung function 1, 3
When to Refer
If spirometry is unavailable or unsuccessful in your setting, refer for specialist opinion rather than making diagnosis based on symptoms alone 3